Stumbling in the crisis?
29/10/20 -"Despite our strong belief in FMC’s robust business model and its ambition to help people with severe illnesses, we have the increasing impression that the company could be better run. Difficult ..."
Pages
56
Language
English
Published on
29/10/20
You may also be interested by these reports :
19/04/24
EssilorLuxottica’s Q1 sales performance was slightly ahead of the market’s expectations. Group revenue grew by 5.5% yoy (+65bp vs the consensus), led ...
19/04/24
Orpea’s 2023 key underlying results met the guidance. The management noted the inflationary staff costs and yet-to-restore occupancy which weighed ...
18/04/24
While the near-term performance is expected to be impacted by various challenges, there are still some promising takeaways from our recent discussion ...
16/04/24
Drägerwerk reported softer-than-expected Q1 24 numbers, with sales declining by 2.6%. As expected, growth in the safety segment partly offset the ...